Rebecca I. Erickson - Concepedia

Author

Rebecca I. Erickson

University of California, Los Angeles

Also Known As

Rebecca I. Erickson

Publications

629

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles WuXi AppTec (China)

About

Rebecca I. Erickson is an author at University of California, Los Angeles specializing in medicine, neurology, and neuroprotection.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	177
2	Neurology	3	3	140
3	Social Sciences	1	1	48
4	Cell Biology	1	1	71
5	Immunology	1	1	37

Rebecca I. Erickson

Publications

629

Citations

H-Index

Page 1

	Year	Citations
MANAGING EMOTIONS ON THE JOB AND AT HOME: UNDERSTANDING THE CONSEQUENCES OF MULTIPLE EMOTIONAL ROLES Amy Wharton, Rebecca I. Erickson Academy of Management Review	1993	398
Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer’s Disease Snahel Patel, William J. Meilandt, Rebecca I. Erickson, Journal of Medicinal Chemistry Selective InhibitorsAlzheimer ’Superior Kinase SelectivityMolecular PharmacologyMedicinal Chemistry	2017	71
Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion Koppany Visnyei, Keith Tatsukawa, Rebecca I. Erickson, Experimental Neurology NeurophysiologyNeuroanatomyPhysiologyCerebral OrganoidSocial Sciences	2005	48
Toxicity Profile of Small-Molecule IAP Antagonist GDC-0152 Is Linked to TNF-α Pharmacology Rebecca I. Erickson, Jacqueline M. Tarrant, Gary Cain, Toxicological Sciences Iap AntagonismApoptosisImmunologyImmune RegulationCell Death	2012	37
Roles of insulin and transferrin in neural progenitor survival and proliferation Rebecca I. Erickson, Andres A. Paucar, Robert L. Jackson, Journal of Neuroscience Research	2008	33
Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats Rebecca I. Erickson, Leah Schutt, Jacqueline M. Tarrant, Journal of Pharmacology and Experimental Therapeutics	2016	21
Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative Diseases Robert A. Craig, Javier de Vicente, Anthony A. Estrada, Journal of Medicinal Chemistry Neurodegenerative DiseasesAmyotrophic Lateral SclerosisIntegrated Stress ResponseMedicineNeurochemical Biomarkers	2024	21

Page 1